Literature DB >> 18420409

2-Aminomethyl piperidines as novel urotensin-II receptor antagonists.

Jian Jin1, Yonghui Wang, Feng Wang, Dongchuan Shi, Karl F Erhard, Zining Wu, Brian F Guida, Sarah K Lawrence, David J Behm, Jyoti Disa, Kalindi S Vaidya, Christopher Evans, Lynette J McMillan, Ralph A Rivero, Michael J Neeb, Stephen A Douglas.   

Abstract

A series of 2-aminomethyl piperidines has been discovered as novel urotensin-II receptor antagonists. The synthesis, initial structure-activity relationships, and optimization of the initial hit that resulted in the identification of potent, cross-species active, and functional urotensin-II receptor antagonists such as 1a and 11a are described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420409     DOI: 10.1016/j.bmcl.2008.03.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists.

Authors:  Rong Jiang; Xinyi Song; Purva Bali; Anthony Smith; Claudia Ruiz Bayona; Li Lin; Michael D Cameron; Patricia H McDonald; Paul J Kenny; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2012-05-04       Impact factor: 2.823

2.  Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures.

Authors:  Francesco Merlino; Salvatore Di Maro; Ali Munaim Yousif; Michele Caraglia; Paolo Grieco
Journal:  J Amino Acids       Date:  2013-02-25

3.  Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Authors:  Andrea Casiraghi; Francesca Longhena; Gaia Faustini; Giovanni Ribaudo; Lorenzo Suigo; Gisela Andrea Camacho-Hernandez; Federica Bono; Viviana Brembati; Amy Hauck Newman; Alessandra Gianoncelli; Valentina Straniero; Arianna Bellucci; Ermanno Valoti
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.